Back to Search Start Over

Natural killer cell receptor variants and chronic hepatitis B virus infection in the Vietnamese population.

Authors :
Auer ED
Tong HV
Amorim LM
Malheiros D
Hoan NX
Issler HC
Petzl-Erler ML
Beltrame MH
Boldt ABW
Toan NL
Song LH
Velavan TP
Augusto DG
Source :
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2020 Jul; Vol. 96, pp. 541-547. Date of Electronic Publication: 2020 May 16.
Publication Year :
2020

Abstract

Objectives: Genes of host immunity play an important role in disease pathogenesis and are determinants of clinical courses of infections, including hepatitis B virus (HBV). Killer-cell immunoglobulin-like receptor (KIR), expressed on the surface of natural killer cells (NK), regulate NK cell cytotoxicity by interacting with human leukocyte antigen (HLA) class I molecules and are candidates for influencing the course of HBV. This study evaluated whether variations in KIR gene content and HLA-C ligands are associated with HBV and with the development of liver cirrhosis and hepatocellular carcinoma.<br />Methods: A Vietnamese study cohort (HBV n = 511; controls n = 140) was genotyped using multiplex sequence-specific polymerase chain reaction (PCR-SSP) followed by melting curve analysis.<br />Results: The presence of the functional allelic group of KIR2DS4 was associated with an increased risk of chronic HBV (OR = 1.86, p <superscript>corr</superscript> = 0.02), while KIR2DL2+HLA-C1 (OR = 0.62, p <superscript>corr</superscript> = 0.04) and KIR2DL3+HLA-C1 (OR = 0.48, p <superscript>corr</superscript> = 0.04) were associated with a decreased risk. The pair KIR2DL3+HLA-C1 was associated with liver cirrhosis (OR = 0.40, p <superscript>corr</superscript> = 0.01). The presence of five or more activating KIR variants was associated with hepatocellular carcinoma (OR = 0.53, p <superscript>corr</superscript> = 0.04).<br />Conclusions: KIR gene content variation and combinations KIR-HLA influence the outcome of HBV infection.<br /> (Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.)

Details

Language :
English
ISSN :
1878-3511
Volume :
96
Database :
MEDLINE
Journal :
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Publication Type :
Academic Journal
Accession number :
32422377
Full Text :
https://doi.org/10.1016/j.ijid.2020.05.033